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Given the increased popularity and use of Complementary and Alternative Medicine (CAM) 
in the treatment of psychiatric disorders, it is crucial for mental health professionals to be 
informed about this treatment approach. Accordingly, this paper critically reviews the pro 
and con arguments for the use of CAM treatment modalities in the treatment of psychiatric 
disorders. Given that there are potential dangers in adopting the CAM approach without 
appropriate supervision, it begs the question of what roles and responsibilities mental health 
professionals have in the matter. Thus, this article proceeds to address the roles and the 
recommended strategies for mental health professionals when working with patients or 
clients who use CAM for their treatment of psychopathological issues. Finally, it goes further 
to discuss the practice of integrating both conventional treatment and CAM to treat mental 
disorders and issues associated with such disorders. Importantly, this article highlights the 
need for knowledgeable, confident, and trained mental health professionals to provide patient 
counselling about the complementary and alternative approach. 
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Utilization of Complementary and 
Alternative Medicine (CAM) for mental 
health problems and psychiatric disorders 
among clients has sparked debate 
regarding the approach. According to 
Ventola (2010a), CAM has been defined 
as “a group of diverse medical and health 
care systems, practices, and products that 
are not presently considered to be part of 
conventional medicine.” The term 
“complementary” indicates that the CAM 
approach is used together with 
conventional medicine, whereas 
“alternative” is a term used to describe 
medical therapies used in place of 
conventional medicine.  
Conventional medicine refers to the 
standard empirical evidence-based 
psychological and pharmacological 
interventions to treat psychiatric disorders 
and related symptoms. The use of 
psychotropic drugs, medical and surgical 
interventions, conventional 
psychotherapies, and biopsychosocial 
interventions to manage and treat mental 
health problems, practiced by medical and 
allied healthcare professionals, are 
therefore considered as conventional. 
 
CAM can include but is not limited to 
(a) alternative whole medical systems 
(homeopathic and naturopathic, Chinese, 
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and Ayurvedic medicine); (b) mind-body 
and spiritual interventions (meditation, 
prayer, mental healing, and art, music, and 
dance therapy); (c) biologically-based 
therapies (herbs, foods, vitamins, and other 
dietary supplements or nutraceuticals 
including natural products such as shark 
cartilage); (d) manipulative and body-
based methods (chiropractic and 
osteopathic manipulation, massage); and 
(e) energy therapies (qi gong, Reiki, 
therapeutic touch, and electromagnetic 
field exposure).  
 
This article aims to highlight some of 
the general arguments for and against 
CAM treatments for psychiatric disorders. 
Then, it will discuss the roles that 
therapists/clinicians can play to encourage 
patients to make an informed decision 
about their use of CAM. Several strategies 
for therapists/clinicians to consider in their 
work with such clients are outlined. The 
move towards an integrative practice 
model is discussed in the final part of the 
article.  
 
The use of CAM 
 
There is a considerable level of CAM 
use among both general and clinical 
populations of people suffering from 
mental health disorders. Across the world, 
the prevalence and patterns of use are 
varied, but frequently, the use of CAM 
approaches involves self-diagnosis and 
self-treatment (Pilkington, 2018). 
According to Kessler et al., (2001), studies 
found that over 50% of those with severe 
depression in the United States (US) 
reported using CAM to treat their 
condition, whereas less than 20% visited 
CAM therapist/providers. Meanwhile, a 
cross-sectional survey investigating the 
use of CAM providers and psychiatric 
outpatient services in people with 
anxiety/depression in Europe revealed that 
17.8 % visited a CAM provider once or 
more in the last 12 months, 11.8 % visited 
psychiatric outpatient services, and 2.5 % 
visited both (Hansen & Kristoffersen, 
2016). In Taiwan, nearly 70% with 
depression reported using at least one form 
of CAM in the past 12 months (Hsu et al, 
2008), whereas in China, a systematic 
review of randomized controlled trials 
found that prescription of Chinese herbal 
medicine in the treatment for depression is 
quite common (Yeung et al., 2015). 
 
Many studies (e.g., Hansen & 
Kristoffersen, 2016; Solomon and Adams, 
2015) reported women as more likely to 
use CAM approach compared to men, 
whereas higher educated people were more 
likely to use the CAM providers’ services 
than the lowest educated. Also, severe 
anxiety and depressive symptoms were 
strongly associated with those who use 
both CAM providers and conventional 
psychiatric services, while those with 
moderate symptoms were found to use the 
CAM approach as the alternative 
pathways.  
 
Various mental health professionals 
adopt the CAM approach as part of their 
practice. Based on clinical experience and 
preliminary data, psychiatrists and 
physicians commonly opt for biologically-
based therapies that are non-FDA 
approved and have minimal risks if they 
feel that a patient has failed to tolerate or 
respond to the conventional medicine 
(Page, 2013). Also, psychological and 
behavioural interventions outlined and 
carried out by psychiatrists, psychologists, 
therapists (including speech and language, 
occupational, and behavioural), 
counsellors, and social workers often 
include the mind-body and spiritual 
approaches (e.g., meditation, prayer, 
mental healing, art, music, and dance 
therapy), the manipulative and body-based 
methods (e.g., yoga, chiropractic and 
osteopathic manipulation, massage, 
relaxation technique, and exercise), and 
the other CAM approaches including 
aromatherapy and electromagnetic field 
exposures.  
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Certain alternative biologically-based 
therapies have shown promising effects on 
treating various psychiatric disorders.  St. 
John’s wort, SAMe (S-adenosyl-L-
methionine), and 5-Hydroxytryptophan (5-
HTP), for example, have been used to treat 
depression as a stand-alone monotherapy 
(Preston & Johnson, 2016). St John’s wort 
provides antidepressant effects through its 
extract which contain the 
naphthodianthrone hypericin, the 
phloroglucinol derivative hyperforin and 
several flavonoids (Butterweck, 2003). 
The chemicals act on the chemical 
messengers in the nervous system that 
regulates mood. Similarly, higher levels 
of SAMe in the serum and cerebrospinal 
fluid raises the levels of dopamine, 
serotonin, norepinephrine, and other 
neurotransmitters in the brain that are 
important for mood regulation (Delle 
Chiaie, Pancheri & Scapicchio, 2002). 
Meanwhile, the 5-HTP is used by the 
body to create serotonin. The 5-HTP 
supplements offer the advantage of 
bypassing the enzymatic conversion 
process of tryptophan hydroxylase which 
can be affected by stress and other factors 
(Palego, Betti, Rossi & Giannaccini, 
2016).  
 
The omega-3 fatty acids (n-3 
Polyunsaturated Fatty Acids) and folic 
acids are commonly used to augment 
antidepressants (Preston et al., 2017). The 
omega-3 fatty acids, for example, contain 
eicosapentaenoic acid (EPA) and 
docosahexaenoic acid (DHA) that helps to 
counter the low blood levels of EPA and 
DHA in people with depression (Hall-
Flavin, 2015). Meanwhile, the folic acids 
in the form of L-methylfolate cross the 
blood-brain barrier and work indirectly to 
facilitate the synthesis of neurotransmitters 
that involved in mood regulation, 
particularly serotonin, dopamine, and 
norepinephrine (Stein, 2013). 
 
The Ginkgo Biloba has been used in 
the treatment of cognitive and memory 
impairment caused by dementia (Wong et 
al., 1998), whereas melatonin has possible 
benefits to counter sleep disturbance, 
although the evidence is not robust 
(Preston et al., 2017). The mechanism of 
how Ginkgo Biloba works in the brain to 
improve cognition is related to its positive 
effect in improving mitochondrial 
dysfunction and dynamics, and neuronal 
plasticity (Stockburger, Eckert, Eckert, 
Friedland-Leuner & Müller 2018). 
 
Numerous clinical trials and reviews of 
CAM therapies for the treatment of mental 
health problems, including some Cochrane 
reviews have been conducted. Although 
the evidence base from high-quality RCTs 
is limited, there is sufficient evidence to 
suggest some efficacy of some of the 
CAM approach. For example, a meta-
analysis study of 27 trials (3808 patients) 
comparing Hypericum perforatum (St 
John's wort) with selective serotonin 
reuptake inhibitors (SSRIs) found 
comparable response and remission rated 
and a lower rate of discontinuation with 
Hypericum (Ng, Venkatanarayanan & Ho, 
2017). However, the findings only applied 
to the treatment of mild and moderate 
depression but not for severe depression. 
Similar findings were reported by Apaydin 
and associates (2016) in their systematic 
review.  
 
Meanwhile, Sharma and associates 
(2017) stated that their preliminary 
findings indicated that SAMe could reduce 
the symptoms of multiple neuropsychiatric 
conditions including certain 
neurocognitive, substance use and 
psychotic disorders and co-morbid medical 
conditions. Moreover, a systematic review 
of clinical studies examining SAMe for 
combating depression found that SAMe is 
equal or even superior in efficacy to 
tricyclic antidepressants in a (Delle Chiaie, 
Pancheri & Scapicchio, 2002). SAMe has 
also been found to be safe and effective 
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adjunctive treatment strategy for selective 
serotonin reuptake inhibitors (SSRIs) 
nonresponders with major depressive 
disorders (MDD) (Alpert et al., 2004). 
Similarly, L-methylfolate supplementation 
has been found to be beneficial and with 
minimal risk for those with MDD that has 
not responded well to conventional 
antidepressant medications (Papakostas et 
al., 2012; Fava & Mischoulon, 2009).  
 
Also, besides its mood-stabilizing 
effects that help with short-term symptoms 
of bipolar disorder and its effective adjunct 
to conventional antidepressants, several 
reports have suggested the potential effects 
of the omega-3 fatty acids (n-3 
Polyunsaturated Fatty Acids) on cognitive 
impairment/dementia, perinatal and 
postpartum depression, schizophrenia, 
borderline personality disorder, attention 
deficit hyperactivity disorder, and 
childhood mood disorders (Mental Health 
America, 2016). 
 
A recent systematic review reported 
potentials for aromatherapy to be used as 
an effective therapeutic option for 
reducing depressive symptoms (Sanchez-
Vidana et al., 2017). The effects of yoga in 
major depressive disorder (MDD) have 
been investigated in seven RCTs, 
highlighting some evidence of positive 
effects beyond placebo (Cramer, Anheyer, 
Lauche & Dobos, 2017). Participants in a 
study of long-term depressive disorders 
experienced a remission more so than did 
controls at 9-month follow-up after 
undergoing meditation with yoga, group 
therapy with hypnosis, and 
psychoeducation (Butler et al., 2008). For 
the late-life mood disorders and cognitive 
aging, evidence shows the beneficial 
effects of exercise, acupuncture and 
relaxation therapies, to a lesser extent 
(Lavretsky, 2009). Also, the evidence for 
the use of acupuncture in treating anxiety 
disorders is becoming stronger (van der 
Watt et al., 2008). 
  
Based on the idea that positive 
emotions can improve human general 
health and well-being, many doctors, 
cancer nurses, and researchers have 
endorsed the use of many complementary 
therapies that concentrate on relaxation 
and reducing stress among cancer patients 
(Cancer Research UK, 2017). Moreover, 
relaxation techniques (including 
aromatherapy, deep breathing, mediation, 
and yoga), music, self-hypnosis, and 
acupuncture have been adopted as part of 
adjunctive therapies to help control or 
reduce pain as parts of clinical pain 
management in adults (Drugs, 2018), 
which can indirectly improve one’s 
physical and mental well-being. Thus, 
based on the availability of evidence in the 
current literature related to the efficacy of 
the CAM approach, it is apparent that the 
CAM approach has some beneficial and 
validated values in the treatment of 
psychiatric disorders. 
 
The use of CAM with children and 
adolescents has been reported (Chan, 
2002), especially for those who suffered 
from co-morbid chronic health conditions, 
experienced a delay in conventional 
treatment due to cost constraints, had 
parents who used CAM, and had parents 
with higher educational levels (Ventola, 
2010a). Children and youth have been 
reported to use CAM treatments to treat 
mental health issues such as anxiety 
disorders, mood disorders, autism, conduct 
disorders, and attention-deficit 
hyperactivity disorder (Chan, 2002; 
Ventola, 2010a). Common CAM therapies 
used by the pediatric population include 
mind-body therapies (e.g., deep breathing, 
yoga, meditation, and art, music, and 
dance therapy), biologically-based 
therapies (dietary-based therapies, mainly 
herbal and dietary supplements) (Kemper 
et al., 2013; Ventola, 2010a), and 
aromatherapy (Laconic, 2014). 
 
The reasons for clients’ preference to 
opt for CAM and factors that contribute 
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towards clients’ resistance and 
noncompliance to conventional medical 
and psychological treatments were 
explored. Contexts like ethnicity, 
socioeconomic status, gender, and culture 
that influence CAM use should not be 
undermined. CAM use is more prevalent 
among women and adults with higher 
incomes and advanced levels of education 
(Ventola, 2010a). The treatment setting 
differences such as the institutional 
atmosphere, mode of payment, and 
frequency and duration of contacts with 
professionals can also influence the 
treatment choice made by patients with 
psychiatric disorders (Anlauf et al., 2015). 
 
In the conventional approach to 
psychiatric disorders, possible distrust in 
psychotherapists from the dominant 
culture can affect the therapeutic alliance 
and thereby influence the use of CAM 
(Bassman, 1997). Moreover, many 
traditional cultures, especially Native 
Americans and Asians, are predisposed to 
the use of CAM (Choi & Kim, 2010; 
Ventola, 2010a). Asian cultures view 
mental health problems as organically 
based and value orientations that shy away 
from open communication with strangers 
about their personal and family conflicts 
(Choi & Kim, 2010). Thus, CAM tends to 
be favored as the first line of treatment as 
it is less invasive. Furthermore, differences 
in dietary practices and the use of 
medicinal herbs in certain ethnic and 
cultural groups that can contribute to 
cross-ethnic and cross-cultural variations 
in drug metabolism can also affect clients’ 
preference to CAM (Lin, 2010).  
 
Many people argue that CAM 
treatments, especially the holistic healing 
approaches involving homeopathy and 
traditional herbal medicine, are not 
something new and untried (Bassman, 
1997). Such treatments have been around 
for thousands of years and have addressed 
the health needs of past populations. In 
comparison to some alternative holistic 
approaches that address all of a person’s 
symptoms at once at the emotional, 
physical, and spiritual level, 
psychotherapy is seen as time- and cost-
consuming. Also, psychotherapy may not 
fit with clients who are nonverbal, less 
intelligent, and those who are not 
comfortable talking about their problems 
that involve having a face-to-face 
conversation and introspection. Using a 
CAM approach allows individuals to 
choose from a variety of treatment options 
in accordance with their learning style and 
lifestyle (Bassman, 1997). 
 
Moreover, many clients reported 
frustration with and distrust of 
conventional medicine because of the 
overprescribing of psychotropic 
medications, as this was perceived as 
downplaying the psychological aspects of 
the illness. Some clients also complained 
about the nature of side effects that 
psychotropic drugs have, while most 
alternative approaches were seen as having 
limited or even no side effects (Bassman, 
1997). For example, Asher and associates 
(2017) found that the risk of treatment 
harms and treatment discontinuation 
attributed to adverse effects was higher for 
SSRIs compared to St. John's wort. Many 
claimed that conventional medicine could 
be a management regime and 
authoritarian, especially for mental 
illnesses that require lifetime medication 
(Bassman, 1997). The CAM approach 
provides them with some flexibility. Also, 
it was argued that pharmacology and 
psychotherapy in conventional medicine 
neglect the prevention side of illness, 
while many holistic modalities can be used 
in both prevention (as prophylactic) and in 
treatment (as therapeutic modalities) 
(Bassman, 1997).  
 
Other reasons attributed to the 
increased use of CAM in recent years may 
include wider information availability on 
the Internet, increased contact with other 
cultures that use CAM, and a growing 
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recognition that various factors contribute 
to health and general well-being (Ventola, 
2010a). 
 
Concern issues over CAM 
 
Researchers have highlighted the 
potential problems of approaching CAM 
as either complementary or as an 
alternative without some precautions. 
Concerns are especially raised in regards 
to the biologically-based therapies such as 
herbal remedies, vitamins, and dietary 
supplements, which are one of the most 
used forms of CAM therapies (Ventola, 
2010a). Scholey and associates (2005) 
stated the pharmaceutical medication that 
is generally processed from the isolation or 
synthesis of active agents is aimed at 
specific targets. However, most 
biologically-based substances used in 
CAM such as the natural herbal remedies 
contain dozens of active components, and 
their non-specified actions with complex 
modulations and interactions may 
negatively affect multiple neuronal, 
metabolic, and hormonal systems. As 
such, they can be detrimental to health and 
even deadly. 
 
Moreover, the herbal, vitamin, and 
dietary supplements market possesses 
some serious ethical and safety concerns 
due to the poor safety monitoring and 
regulations in the industry. These 
unregulated products are independently 
tested with no assurance of the strengths, 
efficacies, and potencies, and have a high 
risk of possible impurities and 
contamination (Preston et al., 2017). The 
misrepresentation issue of naturalness is 
concerning, mainly because naturalness 
does not guarantee harmlessness. Rather, 
some of the products have been found to 
contain risky toxic substances, including 
arsenic, lead, cadmium, and mercury 
(Anlauf et al., 2015). Thus, due to the 
scarcity of research evidence on efficacy 
and safety, the unsupervised use of CAM 
among psychiatric patients can result in 
lethality―especially for patients who have 
other comorbid medical disorders such as 
diabetes, cardiovascular disease, and other 
serious acute and chronic conditions. 
Ventola (2010b) highlighted the 
importance of creating policies and 
practices of CAM guided by a rigorous 
analysis of the impact of such use on the 
patient’s care and condition, the medical 
order, and thorough documentation of such 
use. Despite this strong recommendation, 
such policies and practices remain 
inconsistent and “wrought with 
confusion.”   
 
Although there is some relevant 
evidence available for CAM, the validity 
of most studies examining the 
effectiveness of specific CAM approach is 
criticised as flawed with serious 
methodological issues, small sample size 
in trials, varied comparison interventions, 
and lack of systematically collated data on 
adverse events or long-term effects 
(Pilkington, 2018). For example, a 
systemic review done by Jorm and 
associates (2006) concluded glutamine, S-
adenosylmethionine, St John's wort, 
vitamin C, omega-3 fatty acids, light 
therapy, massage, art therapy, 
bibliotherapy, distraction techniques, 
exercise, and relaxation therapy can have 
some benefits for the treatment of 
depression in children and adolescents. 
However, the study also strongly 
emphasized that the evidence was limited, 
that the findings are mixed and generally 
came from poor quality research, and that 
many methodologies adopted were flawed. 
Furthermore, the evidence for the efficacy 
of the majority of complementary and 
alternative interventions used to treat 
anxiety and depression remains poor (van 
der Watt et al., 2008). For example, a 
twenty-six trials of the omega-3 fatty acids 
(n-3 Polyunsaturated Fatty Acids), 
involving 1438 participants that were 
included in a Cochrane review found that 
only a 'small-to-modest' benefit was shown 
for the supplement, but the evidence was 
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judged to be very low quality, and did not 
appear to be clinically significant 
(Appleton, Sallis, Perry, Ness & Churchill, 
2015). Similarly, inconclusive evidence 
was found in a recent systematic review of 
RCTs that assessed the effectiveness and 
safety of acupuncture for the treatment of 
MDD (Sorbero et al., 2016), and while 
hypnosis has been found to significantly 
alleviate preoperative anxiety in adult 
patients (Saadat et al., 2006), researchers 
argued that the number of studies to 
support its use is very limited, and 
concluding it as effective treatment would 
be premature (Pilkington, 2018). Also, a 
randomized, partially double-blind, 
placebo-controlled study on homeopathy 
for depression reported inconclusive 
evidence on the approach's effectiveness 
(Adler et al., 2013). Despite this, it is 
confusing to find that such lack of valid 
evidence has not diminished the popularity 
of such interventions within the general 
population (van der Watt et al., 2008). 
Most patients did not inform their 
doctors that they were taking some dietary 
and herbal supplements with the 
prescribed medications (Preston et al., 
2017). It was estimated that only about 
35% of patients discussed their CAM use 
with the psychiatrist (Pilkington, 2018). 
According to Ventola (2010c), such 
neglect has raised heavy concerns about 
the dangers of unintended drug-
supplement interactions, the potential for 
serious adverse reactions, toxicity, 
adulterants, individual economic risks in 
treatments, dosage variability issues, and 
the potential risks to special populations of 
children, pregnant women, patients 
undergoing surgery, and 
immunocompromised patients, among 
others. The potential harm can affect 
clients/patients directly through drug-drug 
interactions, and indirectly by delaying 
conventional care that has been proven to 
be effective.  
 
Many patients use CAM concurrently 
with their conventional medicine 
(Solomon & Adams, 2015). The potential 
concerns of the pharmacokinetic and 
pharmacodynamic drug interactions with 
naturopathy, herbal medicines, and dietary 
supplements have been reported. Findings 
suggest such interactions can seriously 
affect hemostasis, liver function, and 
healing through affecting the prescribed 
medications and other healing agents’ 
responses (Ventola, 2010c). Potential drug 
interactions can occur with the common 
herbal remedies and dietary supplements. 
These include (but are not limited to) 
garlic, St John's wort, Gingko Biloba, 
ginseng, licorice, grapefruit juice, and 
traditional Chinese medicines (Ventola, 
2010c). 
 
Meanwhile, Anlauf and associates 
(2015) refuted the claim that the CAM 
approach is “holistic” as it is “neither 
proven at a pathophysiologic level nor in 
terms of clinical efficacy.” Moreover, if a 
patient is using CAM as a complementary 
rather than alternative treatment, more 
spending is needed rather than saving 
costs. Thus, the cost-saving claim made by 
CAM users is untrue in many cases. Also, 
even though patients’ preference should be 
heard, mental health professionals are 
responsible, like everyone else in the 
medical and health fields, to pursue 
explanations and evidence instead of 
conveniently or readily fulfilling the 
desires of their often insufficiently 
informed patients. Importantly, researchers 
have argued that the efficacy context of 
CAM treatment is problematic because it 
is rooted in either therapeutic pseudo-
placebos or pure-placebos as a result of 
positive expectations and experiences. 
Furthermore, placebos can also trigger 
negative effects as per expectation, such 
that the placebo has nocebo effects that 
have clinical significance (refer to Anlauf 
et al., 2015 for more details).  
 
Finally, Preston and Johnson (2016) 
stated that there are people who self-
diagnose their conditions and adopt the 
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CAM approach to self-treat. This is a 
potentially dangerous practice, especially 
when people who have undiagnosed 
bipolar disorder begin taking St. John’s 
wort, SAMe, or 5-HTP (the mood-altering 
agents used to reduce depressive 
symptoms). The drug can provoke 
switching into a manic episode within 3–5 
weeks, just like the conventional 
antidepressants would work. Thus, the 
CAM treatment needs to be carefully 
evaluated and medically supervised by the 
mental health team. 
 
To sum up, high concerns for the use 
of CAM approaches are mainly associated 
with the use of biologically-based 
therapies. Many patients/clients who 
adopted the CAM approach have 
inadequate information on its usefulness, 
research efficacy and validity, drug 
interactions, side effects, dosages, and 
alternatives. However, under the right 
evaluation, patient/client education, and 
supervision from the mental health 
professionals who are equipped with the 
background knowledge of CAM to ensure 
efficacy and minimal risks, the approach 
can provide endorsement to individual’s 
preferences and values.  
 
Roles and strategies for mental health 
professionals 
 
Increased popularity and use of CAM, 
especially in the treatment of mental 
disorders, has highlighted the need for 
better-informed mental health 
professionals to be able to provide patient 
counseling about the approach (Ventola, 
2010a). However, studies found health 
care professionals currently lack the 
knowledge, confidence, and training to 
provide such services (Ventola, 2010a).  
 
According to Page (2013), it is 
important for mental health professionals 
and treating physicians to be equipped 
with the right way to communicate and 
discuss CAM particularly because 
exaggerated claims may lead to a lawsuit 
for malpractice or hauled before the 
medical/ health professional board. On the 
other hand, if clinicians posited themselves 
in a hard way about CAM and 
communicated it to the patients, this may 
end up alienating patients who might be a 
CAM’s strong believer. Thus, it is 
important for professionals to be as non-
judgmental as possible. 
 
Providing patient education about 
CAM is crucial particularly for individuals 
who suffer from chronic and severe 
psychiatric disorders. These patients need 
conventional medicine to treat or stabilize 
their symptoms and disorders to prevent 
relapse or worsen their condition. Using 
CAM without medical supervision in these 
cases can be very dangerous and may cost 
lives. Thus, therapists/clinicians should 
encourage patients to adhere to 
conventional treatment.  
Factors that contribute to 
noncompliance and low adherence to 
conventional medicine in patients may 
include the negative experiences of the 
side effects of medications, fear of being 
drug dependent, the negative stigma 
surrounding medicating the mentally ill, 
financial concerns, ineffective 
consultations, cultural and cross-cultural 
beliefs and differences, the patient’s 
attitude towards medication, expectations 
of the drug’s effectiveness, lack of social 
support, and poor quality of the therapeutic 
alliance (Preston et al., 2017). These 
contextual factors highlight the role of 
biopsychosocial interventions and the 
importance of the therapeutic alliance and 
adopting strategies like psychoeducation 
(Bennett, 2011; Preston et al., 2017). 
Encouragement of compliance and 
adherence to medical treatment can only 
be effective if the therapeutic alliance has 
been established early on. 
 
Several ways to help patients’ 
adherence to conventional medicine 
through a trustful therapeutic alliance may 
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difficulties of taking medication, outlining 
the realistic benefits, discussing possible 
adverse effects, discussing consideration 
of treatment alternatives within the 
conventional approach, and having regular 
follow-up meetings once the patient has 
started a course of psychotropic 
medication (Mitchell & Selmes, 2007). 
Further, encouraging clients/patients to 
discuss their treatment concerns openly 
can benefit both the therapeutic alliance 
and adherence to treatment (Preston et al., 
2017). 
 
The influence of culture on the use of 
CAM highlights the importance of 
community psychoeducation and outreach 
to increase accessibility and usability of 
mental health services. There is a need to 
improve the language gap between mental 
health providers and culturally-diverse 
patients (Choi & Kim, 2010). Besides 
being culturally sensitive towards patients’ 
values, a discussion on the patient’s 
perception of the “meaning” attached to a 
given medication, psychotherapy, and the 
diagnostic label can be initiated by 
therapists/clinicians to assess patients’ 
perceptions and risk for noncompliance 
(Preston et al., 2017).  
 
Noncompliance with conventional 
treatment has been found to be high 
especially in patients with dependent and 
borderline personality disorders, anxiety 
disorders, and paranoia (Preston et al., 
2017). If the mental health professional 
can positively communicate with patients 
about their diagnosis, medication, and 
treatment effectively at the early stage of 
treatment, patients can develop more 
positive attitudes towards their treatment 
(Preston et al., 2017). 
 
Therapists/clinicians are likely to 
encounter patients/clients who report in 
counseling or psychotherapy sessions that 
they are using, interested in, or seeking 
information about alternative treatment 
modalities (Preston et al., 2017). Thus, the 
collaboration between physicians 
/psychiatrists and therapists can enhance 
communication about patients' diagnosis, 
etiology, symptoms, and best treatment 
options. Therapists can be crucial in 
supplying information regarding diagnosis 
and treatment response (Preston et al., 
2017). Since nonmedical therapists like 
psychologists and social workers are often 
required to work directly in monitoring 
patients’ responses to medication in many 
settings, it is important for them to know 
psychopharmacology, at least at the basic 
level.  
 
Therapists/clinicians should also play 
an important role in assessing every 
patient’s/client’s use of the CAM approach 
as part of the routine history-taking and 
diagnostic assessment, and educate them 
on which alternative therapies are 
established (e.g., relaxation therapies, 
chiropractic care, biofeedback, and 
hypnosis) and less established (e.g., herbal, 
high dose vitamin regimens, and other 
dietary supplements) (Preston et al., 2017). 
Within the scope of biologically-based 
therapies in CAM, Ventola (2010b) 
recommended mental health professionals 
emphasize only evidence-based use and 
restrict patients/clients use to only 
products that have undergone quality 
assurance testing. Verifying the licensure 
and checking the record of patients’ 
alternative care provider with the 
associated CAM board are also 
recommended (Page, 2013). Additionally, 
psycho-medical education including 
information that either supports or 
contradicts the use of treatment or product 
should be provided so that clients can 
make an informed decision. Given that 
therapists/clinicians lack the expertise to 
make specific psychopharmacological 
recommendations, clients/patients should 
be referred to appropriate experts (e.g., 
psychiatrists, physicians, pharmacists, 
nutritionist, and dietitians) to address their 
CAM issues and medication concerns. 
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The practice of integrative medicine 
 
There is a rise in integrative practice in 
the medical field (Ernst, 2000), partly due 
to an increase in clients’ interest in 
incorporating certain alternative therapies 
and treatments in the delivery of 
healthcare. The benefits of an integrative 
practice model have been reported. For 
example, in the mental health field, a 
recent program combining emotion-
focused cognitive therapy and acupuncture 
for the treatment of patients with 
depressive symptoms showed a significant 
influence in reducing depressive 
symptoms (Zhang & de Guzman, 2016). 
 
However, such practice is not without 
challenges and criticisms (Ventola, 2010a; 
Ventola, 2010b). There is a significant 
lack of methodologically rigorous studies 
within the CAM field. Despite the lack of 
valid data on its safety and effectiveness 
(particularly for the pediatric population), 
there are tremendous efforts to market the 
herbal and dietary products and other 
CAM approaches to the general 
population. Integrating controversial CAM 
treatments and approaches that are not 
evidence-based with conventional 
medicine can be considered unethical 
practice (Anlauf et al., 2015).  
 
Thus, CAM treatments that are used by 
patients and endorsed by mental health 
professionals should be evidence-based, 
from clinically relevant results of 
randomized controlled studies and 
corresponding meta-analyses―just like the 
science-oriented conventional treatments. 
Any medicines and methods that do not 
exceed a placebo effect should not have 
any place in therapeutic practice, and both 
conventional and alternative components 
in the integration must provide an 
individual and provable contribution 
(Anlauf et al., 2015).  
 
The development of an integrated 
healthcare system rooted in appropriate 
regulations and supported by rigorous 
scientific evidence should be the next 
direction for this field (Ross, 2009; Ernst, 
2000); only then can CAM knowledge be 
seen as necessary with regard to being 
fully integrated into mental health studies 
(and in the training), and continuing 
education of mental health professionals. 
However, to advance the integration 
professionally with evidence-based 
practice, more funding and higher vested 
academic and research interest should be 
made available. Collaborations with the 
big pharmaceutical companies and 
independent bodies may even be 
beneficial. 
 
Conclusion 
 
Many clients choose the CAM 
approach for various reasons. Alternative 
medications and treatments have both pros 
and cons. While some of the treatment 
modalities in the CAM approach have 
proven to be beneficial, others should be 
used with caution. Even where there is 
strong evidence to support the use of 
certain CAM approach, there may be 
factors preventing a wider clinical 
application for them due to concerns 
related to interactions or lack of the  
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